134 related articles for article (PubMed ID: 9039961)
41. Aldose reductase mRNA expression and its activity are induced by glucose in fetal rat aortic smooth muscle (A10) cells.
Tawata M; Ohtaka M; Hosaka Y; Onaya T
Life Sci; 1992; 51(10):719-26. PubMed ID: 1513200
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
43. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
[TBL] [Abstract][Full Text] [Related]
44. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
45. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes.
Chang KC; Paek KS; Kim HJ; Lee YS; Yabe-Nishimura C; Seo HG
Mol Pharmacol; 2002 May; 61(5):1184-91. PubMed ID: 11961137
[TBL] [Abstract][Full Text] [Related]
46. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity.
Kolb NS; Hunsaker LA; Vander Jagt DL
Mol Pharmacol; 1994 Apr; 45(4):797-801. PubMed ID: 8183257
[TBL] [Abstract][Full Text] [Related]
47. Maturation of aldose reductase expression in the neonatal rat inner medulla.
Schwartz GJ; Zavilowitz BJ; Radice AD; Garcia-Perez A; Sands JM
J Clin Invest; 1992 Oct; 90(4):1275-83. PubMed ID: 1401064
[TBL] [Abstract][Full Text] [Related]
48. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
Sato S; Mori K; Wyman M; Kador PF
Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
[TBL] [Abstract][Full Text] [Related]
49. Comparison of aldose reductase inhibitors by determination of IC50 with bovine and rat lens extracts.
Müller P; Hockwin O; Ohrloff C
Ophthalmic Res; 1985; 17(2):115-9. PubMed ID: 3920598
[TBL] [Abstract][Full Text] [Related]
50. Aldo-keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells.
Lyon RC; Li D; McGarvie G; Ellis EM
Neurochem Int; 2013 Jan; 62(1):113-21. PubMed ID: 23084985
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of aldose reductase activity stimulates starvation induced autophagy and clears aldehyde protein adducts.
Zhang D; Bhatnagar A; Baba SP
Chem Biol Interact; 2019 Jun; 306():104-109. PubMed ID: 30998906
[TBL] [Abstract][Full Text] [Related]
52. Semi-quantitation of mRNA by polymerase chain reaction. Levels of oxidative defense enzymes and aldose reductase in rat lenses cultured in hyperglycemic or oxidative medium.
Khanna P; Wang L; Ansari NH
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):3-18. PubMed ID: 8733824
[TBL] [Abstract][Full Text] [Related]
53. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
Liu S; Das B; Srivastava SK
Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
[TBL] [Abstract][Full Text] [Related]
54. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Varagiannis E
Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
[TBL] [Abstract][Full Text] [Related]
55. Activated and unactivated forms of human erythrocyte aldose reductase.
Srivastava SK; Hair GA; Das B
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
[TBL] [Abstract][Full Text] [Related]
56. Oxidized aldose reductase: in vivo factor not in vitro artifact.
Grimshaw CE; Lai CJ
Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700
[TBL] [Abstract][Full Text] [Related]
57. Identification and characterization of aldose reductase in cultured rat mesangial cells.
Kikkawa R; Umemura K; Haneda M; Kajiwara N; Maeda S; Nishimura C; Shigeta Y
Diabetes; 1992 Sep; 41(9):1165-71. PubMed ID: 1499867
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.
Iqbal Z; Morahan G; Arooj M; Sobolev AN; Hameed S
Eur J Med Chem; 2019 Apr; 168():154-175. PubMed ID: 30818176
[TBL] [Abstract][Full Text] [Related]
59. Comparative study of hydrogen peroxide- and 4-hydroxy-2-nonenal-induced cell death in HT22 cells.
Ishimura A; Ishige K; Taira T; Shimba S; Ono S; Ariga H; Tezuka M; Ito Y
Neurochem Int; 2008; 52(4-5):776-85. PubMed ID: 17977619
[TBL] [Abstract][Full Text] [Related]
60. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
